India tomato fever therapeutics market may register growth during the forecast period, 2024-2028, on the backbone of increasing instances of the disease among the population of the country. Sudden increase in the cases along with the demand for the symptomatic control over the diseases and related pharmaceutical drives the growth of the India tomato fever therapeutics market in the upcoming five years. Increasing threat of infectious diseases and recent outbreak of the COVID-19 and causing pandemic is also influencing the population to look for the effective drugs and therapeutics to control the infection also supports the growth of the India tomato fever therapeutics market in the next five years.
Growing Instances Drive Market Growth
Rapidly increasing instances of tomato fever is the major factor driving the growth of the India tomato fever therapeutics market in the upcoming five years. Surge in the number of cases is majorly from the southern region of the country. States like Tamil Nadu, Karnataka, and Andhra Pradesh are at high alert against the diseases. Precautionary steps are taken to modulate the increasing cases. Every person crossing the borders with Kerala is being tested to identify the potent carriers of the infection and infected to control the spread of infection in rest of the country.
The infection emerges from the Shigella bacterium and is often transferred through food or unhygienic water. Although complete causes for the infectious diseases are not yet determined. Cities like Kollam, Neduvathur, Anchal, Aryankavu in the state of Kerala have by far shown significant increase in the number of cases. Government run food and childcare center, Anganwadi centers have been temporarily restricted from functioning. The step is to control further increase of the tomato fever cases. The disease is widespread among the children younger than 5 year old.
Demands For Symptomatic Relief Fuels Market Growth
Tomato fever is a comparatively new infection and the medicines to control the infection of to cure the disease have not yet been formularized. Before commercializing the medicines and other therapeutics specific for the disease, the approvals and clinical trials would take long time. In such circumstances, the demand for the symptomatic relief increases and thus aids the growth of the India tomato fever therapeutics market in the future five years. The symptoms include tomato sized rashes (thus the name of the diseases), along with skin irritation, dehydration to the patient, and in certain cases, worms from the boils have also been reported.
Surging demands for the anti-inflammatory drugs, and pain relievers are actively driving the growth of the India tomato fever therapeutics market in the next five years. Symptomatic control is necessary for the relief of the patient, moreover, the experts announce that the infection is currently self-limiting, and the symptoms usually resolve with time and care. Maintenance of the hygienic conditions like sanitizing the personal belongings maintaining distance with the infected and not using the stuff without sanitization would help in controlling the spread of the infection among other population.
Click here to download the sample
Market Segmentation
The India tomato fever therapeutics market segmentation is based on drug type, route of administration, distribution channel, regional distribution, and competitional landscape. Based on drug type, the market is further segmented into pain relievers, non-steroidal anti-inflammatory drugs, and nucleoside analogue antivirals. By route of administration, topical, oral, and intravenous. Based on distribution channel, the market is bifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. The India tomato fever therapeutics market analysis also studies the regional segmentation divided among North India region, South India region, East India region, and West India region. Each region in the country is further analyzed for the top 3 states of the market.
Company Profile
Johnson & Johnson India Limited, GlaxoSmithKline Pharmaceuticals Ltd., Takeda Pharmaceuticals India Pvt. Ltd., Emergex Vaccines Holding Ltd., CJ HealthCare Corp., are some of the major market players in the country that lead the market growth analysis.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018 – 2021 and 2024 – 2028 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | · Drug Type · Route of Administration · Distribution Channel |
| Regional scope | North; South; East; West; |
| Key companies profiled | Johnson & Johnson India Limited, GlaxoSmithKline Pharmaceuticals Ltd., Takeda Pharmaceuticals India Pvt. Ltd., Emergex Vaccines Holding Ltd., CJ HealthCare Corp. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
